UNITY BIOTECHNOLOGY

Serial Number 88054678
Registration 5720488
700

Registration Progress

Application Filed
Jul 26, 2018
Under Examination
Approved for Publication
Jan 22, 2019
Published for Opposition
Jan 22, 2019
Registered
Apr 9, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-09) (Grace Period Filing)
Due: Oct 09, 2025 Grace Period - 64 days
Original deadline was Apr 09, 2025 (overdue)

Trademark Image

UNITY BIOTECHNOLOGY

Basic Information

Serial Number
88054678
Registration Number
5720488
Filing Date
July 26, 2018
Registration Date
April 9, 2019
Published for Opposition
January 22, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 9, 2019
Registration
Registered
Classes
005

Rights Holder

UNITY BIOTECHNOLOGY, INC.

03
Address
3280 Bayshore Boulevard, Suite 100
Brisbane, CA 94005

Ownership History

UNITY BIOTECHNOLOGY, INC.

Original Applicant
03
Brisbane, CA

UNITY BIOTECHNOLOGY, INC.

Owner at Publication
03
Brisbane, CA

UNITY BIOTECHNOLOGY, INC.

Original Registrant
03
Brisbane, CA

Legal Representation

Attorney
John A. Hughes

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-09)
Due Date
April 09, 2025
Grace Period Ends
October 09, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

14 events
Date Code Type Description Documents
Apr 9, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 9, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 22, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 2, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 17, 2018 ALIE A ASSIGNED TO LIE Loading...
Nov 26, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 26, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 26, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 26, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 26, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 2, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 30, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for assessment, treatment, and prophylaxis of osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, neurological disease, cognitive impairment, and mitochondrial health
First Use Anywhere: Apr 6, 2018
First Use in Commerce: Apr 6, 2018

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOTECHNOLOGY"